Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 February 2024 | Story Leonie Bolleurs | Photo SUPPLIED
Tebogo Motsei
Tebogo Motsei, a PhD student in Physics at the UFS, has been awarded the prestigious CV Raman International Fellowship for African Researchers.

Imagine a supercapacitor/battery made right here in South Africa that could change the way we store energy for the better. A product that can store energy in real time, thus solving energy problems as they happen, which makes a huge difference especially during power outages. A product that is not just good for the environment – transitioning away from lithium-ion batteries – but that can also create jobs and boost the local economy.

What we are talking about is a type of technology known as a sodium-ion supercapacitor/battery, which is the focus of Tebogo Motsei’s research. This technology serves as a power source for lighting, power plants, cars, and phones. Motsei, a PhD student in the Department of Physics on the Qwaqwa Campus of the University of the Free State (UFS), explains that – unlike lithium batteries, which have undergone extensive research and are expensive to produce – they are conducting experimental work and characterisations to determine if sodium-ion supercapacitor/batteries can perform as well or even better, using more affordable and eco-friendly materials.

“Our results, inspired by the urgent need for improved energy storage solutions in South Africa amid its energy challenges, have been very promising. We have successfully developed a sodium-ion supercapacitor/battery that stores as much energy as a lithium-ion battery. Moreover, it was crafted from recycled materials, making it a more cost-effective and environmentally friendly option,” states Motsei, adding that their battery is unique, as no one else in the world has created anything quite like it, despite numerous attempts.

She is also pleased with this supercapacitor/battery’s ability to repair itself. Motsei explains, “Imagine if your toy could fix itself whenever it got broken – that's kind of what our sodium-ion supercapacitor/battery does!”

Motsei is part of a group of scientists in the Department of Physics at the UFS who are working on this research and who have published a scientific article on their work, titled Composite super-capacitor/Na-ion battery with self-healing Fe–Cr alloy electrodes. 

“We're proud of what we have accomplished,” she remarks.

Fellowship: a dream come true

Being part of this impactful research contributed to Motsei receiving the prestigious CV Raman International Fellowship for African Researchers (2023). The fellowship is for African researchers engaged in research at an African institution, providing opportunities for research collaboration in India. Motsei will be the only candidate from South Africa.

This award is merit-based. Motsei attributes her selection to factors such as her strong academic record, research accomplishments, and innovative approach to solving complex problems. She also believes her experience in research, collaboration, and publication reflects her potential to make meaningful contributions to the field during the fellowship period. 

Another key factor contributing to her selection for this fellowship is her skill in fabricating actual devices/prototypes. “The hands-on nature of this research, allowing me to create devices from scratch, has always been my passion. Making my first device – the ‘Magnetron Sputtering Unit’ – during my master’s studies, was a turning point. It made me realise that I had made the best decision ever by choosing this research field. I'm truly passionate about my work,” says Motsei. 

For her PhD studies, she is supervised by Prof Richard Ocaya, Associate Professor in the Department of Physics, and co-supervised by Dr Kamohelo Tshabalala, Senior Lecturer in the Department of Physics. Prof Ocaya, proud of Motsei’s achievements, believes that this fellowship not only serves as a great motivation for students – especially on the Qwaqwa Campus – but also highlights the global relevance of the UFS, particularly the Department of Physics.

Motsei says receiving this fellowship is a dream come true and a profound, life-changing moment for her. “I feel deeply honoured to be concluding this programme at the CSIR-Electrochemical Research Institute, the host institution in India, under the guidance of Prof Arul Manuel Stephan, whose invaluable assistance has been instrumental in my preparations.” Motsei also expressed her gratitude towards everyone who has supported her during this process, including Sudhir Kumar from the Indian Embassy in Pretoria.

“I am excited about how I can use this opportunity to make a difference. Whether it’s tackling significant global energy issues or finding new ways to solve everyday problems, I know this fellowship will give me the tools and support needed to make a real impact. Overall, I see this fellowship as a stepping stone to exciting new opportunities and adventures in the world of research,” she comments.

Making a meaningful impact

Motsei will be leaving for India on 23 February for a period of six months. She is excited about this new chapter in her research journey. “This fellowship will enhance my abilities as a scientist and leader in physics, providing me with essential skills, connections, and experience to make a meaningful impact in science and energy. I'm genuinely happy about this opportunity, which I thank God for.”

  • Sir Chandrasekhara Venkata Raman, after whom the fellowship is named, was a renowned Indian physicist who made great contributions to physics, winning many prizes and awards, including the 1930 Nobel Prize in Physics. He was known for his work in the field of light scattering and was the first Asian and non-European to receive a Nobel prize in any branch of science. 

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept